Stephanie Ware, MD, PhD

Bio

Stephanie M. Ware, MD, PhD, is a Professor of Pediatrics and Medical and Molecular Genetics, Vice Chair of Clinical Affairs in Medical and Molecular Genetics, and Program Leader in Cardiovascular Genetics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine.  Dr. Ware graduated Summa cum laude with highest honors in Zoology from Butler University. She earned her MD and PhD degrees at the University of Cincinnati College of Medicine where she was elected to Alpha Omega Alpha Honor Society. She completed her pediatric residency and clinical genetics fellowship at Baylor College of Medicine in Houston, Texas.  Dr. Ware’s research interests include the genetic and developmental basis of disorders of cardiac structure and function. Her research laboratory has made significant contributions in the areas of congenital heart defects and cardiomyopathy. Dr. Ware is a member of the American Heart Association, the American Society for Human Genetics, the Society for Pediatric Research, the American Society for Clinical Investigation, and is Faculty of the American College of Medical Genetics and Genomics. She has received a number of scholarly awards for her research. Dr. Ware has a longstanding track record of independent funding from the NIH and multiple foundations for basic and translational research. In addition, she participates in multi-site initiatives including serving as PI of the Genetic Coordinating Center for the NHLBI funded study to identify genotype-phenotype correlations in pediatric cardiomyopathy and serving as PI for the Cytogenomics of Cardiovascular Malformations Consortium. The long term goals of the clinical, translational, and basic research approaches are to identify causes and potential management of disorders of cardiac structure and function.  Clinically, she evaluates and manages patients with genetic disorders and has specific expertise in cardiomyopathy and syndromes with cardiovascular disease. She was recruited to IUSM in March, 2014 to initiate a cardiovascular genetics program that would encompass clinical cardiovascular genetics services and basic and translational cardiovascular genetics research.